Company
Climb Bio, Inc. (CLYM)
Standardized SEC financial data for Climb Bio, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001768446 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-37.3%
Free cash flow
-$54.5M
Current ratio
15.16×
EPS (diluted)
$-0.88
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $8.8M | $23.3M | $26.2M | $15.4M | $14.3M | $46.7M |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $20.5M | $161.4M | $123.6M | $93.1M | $87.2M | $160.7M |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$14.1M | -$36.1M | -$37.4M | -$20.6M | -$15.6M | -$54.4M |
| Capital expenditures |
Get CLYM data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CLYM/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CLYM/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"